Actively Recruiting
Corazones Unidos Study
Led by University of Arizona · Updated on 2025-12-23
45
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CVD is the leading cause of death among individuals with MASLD, a risk factor for liver cancer. In Southern Arizona, CVD and cancer (including liver and gastric cancer) are among the leading causes of death for Mexican-origin adults.1 Given Mexican-origin adults' disproportionate burden of CVD-related mortality37 and higher rates of MASLD compared to other ethnic/racial groups; we urgently need to develop contextually tailored strategies for management of CVD risk factors and outcomes. Thus, the purpose of this study is to examine the acceptability and feasibility of a community health worker (CHW)-led intervention aimed to increase cardiovascular risk awareness and promote lifestyle modifications among Mexican-origin adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Southern Arizona region. The proposed project has the potential to improve health outcomes for this vulnerable population and contribute to the ACS-CHERC's overarching goal of improving health equity for Hispanic communities and family caregivers.
CONDITIONS
Official Title
Corazones Unidos Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be Mexican-origin or of Mexican descent
- Be 18 years of age or older
- Have a confirmed MASLD diagnosis (CAP score of 248 dB/m or higher)
- Have an adult member of your social network within 25 miles interested in participating
- Be able to provide informed consent
- Be able to speak, read, and write English and/or Spanish
- Social support participants must be 18 or older
- Social support participants must be a first-degree blood relative or spouse/significant other
- Social support participants must be able to provide informed consent
- Social support participants must be able to speak, read, and write English and/or Spanish
You will not qualify if you...
- Ongoing or recent alcohol consumption exceeding 21 standard drinks per week for men or 14 for women
- Previous diagnosis of liver cancer
- Regular use of anti-inflammatory or liver-toxic medications
- Taking medication for psychiatric disorders
- Diagnosis of depression
- Diagnosis of autoimmune disorders
- Women who are pregnant or breastfeeding
- Social support participants living more than 25 miles from the intervention participant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UA Collaboratory for Metabolic Disease Prevention & Treatment
Tucson, Arizona, United States, 85714
Actively Recruiting
Research Team
A
Adriana Maldonado Assistant Professor, PhD
CONTACT
E
Edgar Villavicencio A Research Coordinator, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here